Immuno-potentiating pathway of HBsAg-HBIG immunogenic complex visualized

Area of Science:

• Immunology
• Vaccinology
• Hepatology

Background:

• Chronic viral hepatitis B (CHB) presents a significant global health challenge.
• A novel therapeutic vaccine, yeast-derived recombinant HBsAg-anti-HBs immunogenic complexes (YIC), has shown efficacy in clinical trials for CHB.
• Understanding YIC's immuno-potentiating mechanisms is crucial for optimizing CHB treatment.

Purpose of the Study:

• To elucidate the cellular mechanisms underlying the therapeutic efficacy of YIC in CHB.
• To investigate the internalization, intracellular trafficking, and dissociation of YIC within antigen-presenting cells.
• To assess the impact of YIC on T cell responses in vivo.

Main Methods:

• Live-cell imaging technology was employed to study YIC internalization and dissociation in vitro.
• Antigen presentation and T cell stimulation assays were conducted in mice following YIC administration.
• Flow cytometry was used to quantify T cell populations producing key cytokines like IFN-γ and TNF-α.

Main Results:

• YIC are internalized by antigen-presenting cells via Fcγ receptors (FcγR).
• YIC undergo intracellular transport through endosomal compartments, with dissociation primarily occurring in late endosomes.
• YIC administration significantly increased the populations of IFN-γ and TNF-α producing CD8+ and CD4+ T cells in mice compared to controls.

Conclusions:

• YIC are processed through a defined endosomal pathway, leading to antigen presentation and T cell activation.
• The study provides mechanistic insights into YIC's function as a therapeutic vaccine for CHB.
• These findings support the further development and application of YIC for treating chronic viral hepatitis B.